GlassScriptPhysician profile
Kimberly Shao
NPI 1891282547
$3,331.56
in general payments reported to CMS, 2019-2025
20 companies · $780 in 2025
The $780 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $121 · 2021: $233 · 2022: $568 · 2023: $496 · 2024: $1,133 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,409.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $606.56 | 2022-2025 | |
| Amgen INC. | $424.30 | 2022-2024 | Otezla |
| Genzyme Corporation | $358.55 | 2020-2024 | |
| Regeneron Healthcare Solutions, INC. | $313.86 | 2021-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $296.95 | 2022-2025 | Ebglyss, Taltz, Olumiant |
| Galderma Laboratories, L.P. | $246.20 | 2022-2025 | Nemluvio |
| Ucb, INC. | $230.96 | 2022-2025 | Bimzelx, Cimzia |
| Janssen Biotech, INC. | $131.84 | 2022-2024 | Tremfya, Stelara, Simponi Aria |
| Mimedx Group, INC. | $127.72 | 2024-2025 | |
| Incyte Corporation | $126.14 | 2024 | Opzelura |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.70 | 2024 | Spevigo |
| Novartis Pharmaceuticals Corporation | $84.20 | 2024-2025 | |
| Kyowa Kirin, INC. | $59.90 | 2021 | |
| Leo Pharma INC. | $54.83 | 2022-2025 | Anzupgo, Adbry |
| Kerecis Limited | $46.22 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $32.95 | 2022-2023 | Xepi, Bf-Rhodoled, Ameluz |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.37 | 2024 | Cabtreo |
| Janssen Scientific Affairs, LLC | $18.56 | 2025 | Tremfya |
| Convatec INC. | $14.42 | 2025 | |
| Helsinn Therapeutics (U.S.), INC. | $14.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Shao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.